Este sitio web utiliza cookies propias para ofrecer un mejor servicio. Si continúa navegando consideramos que acepta su uso. Encontrará más información en nuestra Política de Cookies.
OK | Más informaciónSolicitudes publicadas en los últimos 30 días / Applications published in the last 30 days
NºPublicación: BR102022014111A2 24/01/2023
Solicitante:
SHARED X LLC [KY]
Resumen de: CA3167540A1
A biostimulant composition produced from hydrolysis of various feedstock are provided.
NºPublicación: US2023020806A1 19/01/2023
Solicitante:
HENNES KILIAN [DE]
Resumen de: US2023020806A1
A device and a method for clinically providing a preparation of autologous phages, namely, those that can verifiably be traced back to originating from a very specific person and preferably are also only intended for use in this one specific person includes a phage culturing device which is a fluid line system that is sealed off with respect to the outside environment The phages in the fluid line system obtained after at least one-time culturing are separated from bacteria by way of filtration, and preferably by way of tangential flow filtration. The phages separated by way of filtration are transferred into a collection vessel that is connected to the fluid line system and are preferably removed from the fluid line system, using the collection vessel, as a usable, preferably autologous preparation.
NºPublicación: US2023015964A1 19/01/2023
Solicitante:
MYTAMAR GMBH [CH]
Resumen de: US2023015964A1
The use of an extract of water-soluble saccharides derived from the Phoenix dactylifera date fruits to protect plants against pathogens. In particular, the application of such an extract is used to stimulate the plant's defence and resistance responses during treatment or prevention, particularly to induce an eliciting activity of the defence mechanisms.
NºPublicación: US2023019438A1 19/01/2023
Solicitante:
HUBEI BIOPESTICIDE ENGINEERING RES CENTER [CN]
Resumen de: US2023019438A1
A BVP10 protein shown in SEQ ID NO:2 for controlling tetranychid mites and use of the protein is provided. The BVP10 protein has a median lethal concentration of 19.07 μg/mL against Tetranychus urticae, a median lethal concentration of 58.05 μg/mL against Panonychus citri, a median lethal concentration of 36.08 μg/mL against Tetranychus cinnabarinus, and a control effect of 79.53%-95.45% against strawberry red spider mites. The protein is provided for preparing a novel mite pesticide.
NºPublicación: AU2021284383A1 19/01/2023
Solicitante:
SOUND AGRICULTURE COMPANY
Resumen de: AU2021284383A1
Disclosed herein are compounds or salts thereof, and compositions thereof, for increasing plant growth. Also disclosed are methods of increasing levels of plant nutrients using a compound, salt, or composition as disclosed herein. Also disclosed herein are kits comprising a compound, salt, or composition as described herein.
NºPublicación: AU2021266078A1 19/01/2023
Solicitante:
EVONIK OPERATIONS GMBH
Resumen de: AU2021266078A1
The present invention relates to the use of compositions comprising at least one compound of the formula (I): R
NºPublicación: AU2021276913A1 19/01/2023
Solicitante:
VIRUSTATIC LTD
HOPE PAUL
Resumen de: AU2021276913A1
A breathable biological face covering comprising a fabric material and an anti-pathogen substance on the fabric material. The anti-pathogen substance comprises a lactoferrin protein. The amount of lactoferrin protein on the fabric material may be in the range of 0.6-1.5 grams/m2 of fabric material. Another embodiment is a lactoferrin composition comprising an aqueous fluid at pH <7.0 and lactoferrin protein mixed in the aqueous fluid at a concentration of 0.6-1.5 grams per liter. This lactoferrin composition may be administered into the respiratory tract. This composition could be useful against respiratory microbial pathogen, such as influenza virus or coronavirus.
NºPublicación: AU2021279438A1 19/01/2023
Solicitante:
STRING BIO PRIVATE LTD
Resumen de: AU2021279438A1
The disclosure relates to whole cell based biostimulant compositions and methods for improving agricultural productivity. In particular, the compositions disclosed herein comprise a microbial consortium having gammaproteobacterial methanotroph. As a result of these methanotrophs, the biostimulant composition enables plant performance improvement, utilization of methane, and facilitates improved nitrogen fixation in plants. The composition also helps in reducing the need of external chemical fertilizers for plant growth, development, performance and/or survival.
NºPublicación: AU2021204127A1 19/01/2023
Solicitante:
MICE AWAY ORGANIC [AU]
Resumen de: AU2021204127A1
Abstract A rodent repelling unit comprises a housing and peppermint oil as the active ingredient. Fig1
NºPublicación: US2023018327A1 19/01/2023
Solicitante:
MONSANTO TECHNOLOGY LLC [US]
Resumen de: US2023018327A1
Engineered Cry1Da amino acid sequences are provided that exhibit improved Lepidopteran insecticidal activity and an enhanced Lepidopteran spectrum compared to the naturally occurring Cry1Da protein toxin. Polynucleotide sequences intended for use in expression of the improved proteins in plants are also provided. Particular embodiments provide compositions containing insect inhibitory amounts of the engineered proteins, as well as recombinant plants, plant parts, and seeds containing polynucleotide constructs encoding one or more of the improved engineered proteins.
NºPublicación: US2023016572A1 19/01/2023
Solicitante:
KOCH AGRONOMIC SERVICES LLC [US]
Resumen de: US2023016572A1
The present disclosure relates to a low temperature stable aqueous formulation of N-(n-butyl) thiophosphoric triamide (NBPT) with stability against crystallization and/or freezing upon exposure to low temperatures of 0° C. or below. Formulations of the present disclosure may also contain water-soluble agents such as microbial strains. The present disclosure also provides methods to make and use the formulation according to the present disclosure.
NºPublicación: US2023016543A1 19/01/2023
Solicitante:
SPOGEN BIOTECH INC [US]
Resumen de: US2023016543A1
Bioactive priming polypeptides are provided that are useful when applied to plants in agricultural formulations. Methods of using the formulations containing the bioactive priming polypeptides are also provided which are applied exogenously to the surface of a plant or a plant cell membrane or endogenously to the interior of a plant or to a plant cell. The bioactive priming polypeptides when applied to a plant, a plant part, or a plant growth medium or a rhizosphere in an area surrounding the plant or the plant part increase growth, yield, health, longevity, productivity, and/or vigor of a plant or a plant part and/or decrease abiotic stress in the plant or the plant part and/or protect the plant or the plant part from disease, insects and/or nematodes, and/or increase the innate immune response of the plant or the plant part and/or change plant architecture.
NºPublicación: US2023013686A1 19/01/2023
Solicitante:
MONSANTO TECHNOLOGY LLC [US]
Resumen de: US2023013686A1
Pesticidal protein exhibiting toxic activity against Lepidopteran and Hemipteran pest species are disclosed, and include, but are not limited to, TIC2199. DNA constructs are provided which contain a recombinant nucleic acid sequence encoding the disclosed pesticidal protein. Transgenic plants, plant cells, seed, and plant parts resistant to Lepidopteran and Hemipteran infestation are provided which contain recombinant nucleic acid sequences encoding the pesticidal proteins of the present invention. Methods for detecting the presence of the recombinant nucleic acid sequences or the protein of the present invention in a biological sample, and methods of controlling Lepidopteran and Hemipteran species pests using TIC2199 pesticidal protein are also provided.
NºPublicación: US2023016040A1 19/01/2023
Solicitante:
NOVOZYMES BIOAG AS [DK]
Resumen de: US2023016040A1
The present disclosure provides isolated Paenibacillus strains useful for fixing atmospheric nitrogen and enhancing crop yield, as well as inoculant compositions comprising one or more of the isolated strains, seeds that have been treated with one or more of the isolated strains, and methods of using the isolated strains to improve nitrogen content, crop yield, etc.
NºPublicación: WO2023286927A1 19/01/2023
Solicitante:
BIOPLAN CO LTD [KR]
Resumen de: WO2023286927A1
A disclosed method for preparing a plant biostimulant for preventing cold injury and enhancing the flowering rate of a plant comprises the steps of: preparing an animal amino acid by hydrolyzing feather meal by means of a protease; and liquefying by mixing the prepared animal amino acid and a reaction material comprising urea, an organic acid and water. Therefore, the present invention can not only prevent cold injury of a plant and enhance the flowering rate of the plant, but also prevent agricultural damage due to climate change.
NºPublicación: WO2023286928A1 19/01/2023
Solicitante:
BIOPLAN CO LTD [KR]
Resumen de: WO2023286928A1
A disclosed method for preparing a plant bioactive agent for enhancing photosynthesis in a plant comprises the steps of: preparing an animal amino acid by hydrolyzing feather meal by using a proteolytic enzyme; and mixing the prepared animal amino acid with reactive raw materials including potassium nitrate, calcium nitrate, magnesium nitrate, organic acid, and water, and liquefying the mixture. Thus, the method can not only enhance photosynthesis in a plant, but also prevent agricultural damage caused by climate change in advance.
NºPublicación: WO2023287712A1 19/01/2023
Solicitante:
SALVEO INC [US]
Resumen de: WO2023287712A1
Provided herein are compositions, systems, and methods for improving or maintaining plant, aquatic, and/or livestock health and/or inhibiting or treating deleterious pathogens. More specifically, the present disclosure relates to biostimulant compositions having elemental metals, one or more organic additives, trace minerals, and an algae extract for the improvement or maintenance of plant, aquaculture, or livestock health and/or for the treatment of harmful plant, aquaculture, or livestock pathogens, and also relates to methods of making and using the compositions.
NºPublicación: WO2023285383A1 19/01/2023
Solicitante:
SIGNIFY HOLDING BV [NL]
Resumen de: WO2023285383A1
The invention provides a lighting system (1000) for indoor microbiome management in an animal residence (200), wherein the lighting system (1000) comprises a light generating device (100), a control system (300), and an input system (305), wherein: the light generating device (100) is configured to generate first device radiation (111), wherein a spectral power distribution of the first device radiation (111) is selected for promoting persistence of the first microbes (7) relative to second microbes, other than the first microbes (7); the input system (305) is configured to receive and/or sense a microbiome influencing parameter and to provide a related input signal to the control system (300); the control system (300) is configured to control the light generating device (100) in dependence of the related input signal.
NºPublicación: WO2023288294A1 19/01/2023
Solicitante:
NOVOZYMES AS [DK]
NOVOZYMES BIOAG AS [DK]
RUSSELL CALLUM [US]
Resumen de: WO2023288294A1
The present disclosure provides compositions and methods for improving the rainfastness of proteins, such as enzymes and cell-signaling peptides, on plants and other surfaces that may be susceptible to infestation and/or infection by bacteria, fungi, etc. Particularly useful are rain fasteners selected from the group consisting of organo-modified siloxanes, such as polyether trisiloxanes.
NºPublicación: EP4118103A1 18/01/2023
Solicitante:
DELPHINUS BIOTECH S R L [IT]
Resumen de: WO2021181355A1
The invention relates to a synthetic fusion protein having high antimicrobial activity. In particular, the invention relates to the use of said protein to eliminate pathogenic microorganisms from environments and surfaces. In particular, the synthetic fusion protein object of the present invention can be used in the preparation of disinfectant solutions that can be used in the outpatient, hospital and domestic field, in high traffic environments, in filters of air inlet and extraction systems or air conditioners or air treatment unit ATU, in environments used for food preparation. In general, in all those areas where it is necessary to adopt antimicrobial prophylaxis directed against gram + bacteria, viruses, mycoplasma and fungi.
NºPublicación: EP4117440A1 18/01/2023
Solicitante:
DELPHINUS BIOTECH S R L [IT]
Resumen de: WO2021181356A1
The invention relates to a synthetic fusion protein having high antimicrobial activity. In particular, the invention relates to the use of said protein in the agricultural field to combat infections caused by plant pathogenic microorganisms.
NºPublicación: EP4118194A1 18/01/2023
Solicitante:
CURIE CO INC [US]
Resumen de: WO2021183680A1
Transglutaminase variants are disclosed. Applications of use for the variants, including use as preservatives, biocidal agents, and for modification of proteins, are disclosed.
NºPublicación: EP4119150A1 18/01/2023
Solicitante:
NUTRI CO LTD [JP]
Resumen de: WO2021182377A1
Provided is a Clostridiodes difficile growth inhibitor. A Clostridiodes difficile growth inhibitor containing killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer, or a detergent for inhibiting growth of Clostridiodes difficile.
NºPublicación: EP4118095A1 18/01/2023
Solicitante:
INTRON BIOTECHNOLOGY INC [KR]
Resumen de: WO2021181235A1
An antibacterial protein against Bacillus with the amino acid sequence as set forth in SEQ ID NO: 1 is disclosed. Also disclosed is a method of preparing an antibacterial protein against Bacillus. The method includes: culturing BL21-pBAD-BAL200 cells, the BL21-pBAD-BAL200 cells including a plasmid that comprising a sequence as set forth in SEQ ID NO: 2; inducing the expression of the antibacterial protein; and purifying the antibacterial protein.
Nº publicación: EP4118982A1 18/01/2023
Solicitante:
KT & G CORP [KR]
Resumen de: WO2022154231A1
A smoking article case having a hand care function may be provided. A smoking article case according to some embodiments of the present disclosure comprises: a body portion having an internal space formed therein for storing smoking articles; and a cover connected to the body portion, wherein a functional care zone may be formed on at least a portion of the outer surfaces of the body portion and the cover. Microcapsules containing functional substances are applied to the functional care zone, and as the functional substances are discharged from the microcapsules crushed by a frictional action of a smoker, a hand care function may be provided to the smoker.